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Abstract: In their recent publication, Rossman et al. [1] describe how the inherent budding 
capability of its M2 protein allows influenza A virus to bypass recruitment of the cellular 
ESCRT machinery enlisted by several other enveloped RNA and DNA viruses, including 
HIV,  Ebola,  rabies,  herpes  simplex  type  1  and  hepatitis  B.  Studies  from  the  same 
laboratory  [2]  and  other  laboratories  [3–6]  indicate  that  budding  of  plasmid-derived  
virus-like  particles  can  be  mediated  by  the  influenza  virus  hemagglutinin  and 
neuraminidase  proteins  in  the  absence  of  M2.  These  events  are  also  independent  of 
canonical  ESCRT  components  [2,7].  Understanding  how  intrinsic  properties  of  these 
influenza virus proteins permit ESCRT-independent budding expands our understanding of 
the budding process itself.  
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1. ESCRT-Dependent Budding 
Budding is an integral part of virus infection where the objective is exit of a protected viral genome 
from  the  infected  cells.  By  necessity,  enveloped  viruses  use  host-derived  membrane  to  form  the 
encapsidating membrane for this purpose. Since nucleic acid and lipid do not have intrinsic affinity for 
each other, the encapsidation process requires proteins to serve as adaptors, as initiators of membrane 
deformation and as mediators of bud scission. The notion that the ESCRT (endosomal sorting complex 
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required for transport; reviewed in [8,9]) machinery is an active participant in this process came from 
identification of Tsg101, a component of ESCRT-1, as a binding partner of the budding determinant 
(i.e., the Pro-Thr-Ala-Pro “Late domain” motif) in the Gag polyprotein of HIV-1 [10–12]. This motif is 
required  for  budding  of  infectious  virus  particles  or  plasmid-derived  virus-like  particles  (VLPs). 
Subsequently, the Late domain motifs P(P)PPY and LYPXnL were found to partner with ESCRT 
machinery  adaptors,  namely  members  of  the  Nedd4  family  of  E3  ubiquitin  ligases  and  Alix, 
respectively (reviewed in [13–15]).  
The topology of enveloped virus budding is similar to that of vesicle budding into the lumen of the 
late endosome/multivesicular body (LE/MVB) that occurs as part of endocytic trafficking. The ESCRT 
machinery  consists  of  four  ESCRT  factors  (ESCRT-0,  -1,  -2  and  3)  and  a  regulating  ATPase, 
Vps4 [8,9,16]. During endocytic trafficking, monoubiquitinated cellular cargo encounters ESCRT-0 on 
the cytoplasmic face of the early endosomal membrane. This molecular interaction initiates sequential 
recruitment of ESCRT-1, ESCRT-2 and ESCRT-3. In the last step, Vps4 disassembles the complex, 
permitting  recycling  of  the  ESCRT  components  into  the  cytosol.  In  contrast,  use  of  the  ESCRT 
machinery by viruses has been found to be remarkably versatile: e.g., rhabdoviruses use the machinery 
while alphaviruses do not [17]. Some members of the paramyxovirus family use the machinery while 
budding of other members appears to be ESCRT-independent [18]. Interestingly, the influenza virus 
M1 protein binds the ESCRT-1 factor Vps28 but the significance of this interaction remains to be 
determined  since  depletion  of  endogenous  Vps28  has  no  detectable  effect  on  influenza  virus 
budding [19]. In this regard, it should be noted that the cellular Rab11 pathway has been implicated as 
an alternative to the ESCRT system for both the influenza and respiratory syncytial viruses [20,21]. 
All retroviruses use ESCRT factors but family members differ based on whether they recruit ESCRT-1, 
-2,  both  or  neither  to  facilitate  budding  events  [22–24];  reviewed in [25]. All  retroviruses recruit 
ESCRT-3 to mediate the final membrane fission event. Thus, viruses exploit the ESCRT machinery in 
a highly selective manner. 
2. ESCRT-Independent, M2-Mediated Budding 
By identifying M2 as the mediator of membrane scission, Rossman et al. [1] provide the prototype 
for an “un-ESCRT-ed” budding mechanism. In the context of the infected cell where all of the viral 
genes  are  expressed,  assembly  and  release  of  influenza  virus  occurs  on  plasma  membrane  rafts 
(reviewed  in  [26]).  Localization  to  rafts  is  driven  by  the  virus-encoded  transmembrane  proteins, 
hemagglutinin (HA) and neuraminidase (NA), which have inherent affinity for the high cholesterol, 
liquid-ordered nature of this membrane microdomain [27]. Protein-protein interaction with HA brings 
the viral matrix (M1) protein into the budding assemblage [26]. M1 recruits the viral ribonucleoprotein 
complexes and the non-raft associated transmembrane protein M2 into the emerging bud. Rossman and 
co-authors [1] propose that M2 protein alone can initiate membrane deformation, bud neck formation 
and bud neck scission and support this hypothesis by demonstrating that (i) expression of M2 alone in 
293T  cells  resulted  in  release of enveloped  M2-containing  particles  into tissue culture  media  and  
(ii) reconstitution of giant unilamellar vesicles (GUVs) with purified M2 protein alone induced the 
accumulation of M2-containing vesicles in the lumen of the GUVs. Moreover, they show that these 
events  can  be  mediated  by  a  synthetic  peptide  containing  the  sequence  of  the  17-amino  acid Viruses 2011, 3                         
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amphipathic helix located in the cholesterol-binding C-terminal cytoplasmic tail of the M2 protein. 
This sequence includes a known cholesterol interaction motif, termed a “CRAC” motif (cholesterol 
recognition/interaction amino acid consensus motif) that is present in several viruses [27]. Mutations 
introduced into the amphipathic helix reduced budding of M2 from the plasma membrane and GUVs. 
However, the fact that M2 does not associate with rafts suggests that its intrinsic cholesterol binding 
property is insufficient to drive budding outside of the context of the in vitro assay. Based on their 
observation that M2 accumulated at the boundary between regions of high and low cholesterol in the 
GUVs, Rossman et al. [1] hypothesize that, in the context of viral replication where all of the viral 
proteins are expressed, M2 accumulates at the boundary between the HA and NA in raft-like lipid 
microdomains of high cholesterol content and the M1-ribonucleoprotein complexes in the adjacent 
plasma  membrane.  The  resulting  phase  separation  in  the  region  between  the  different  membrane 
microenvironments is suggested to induce a line tension (i.e., a departure from the basal energy level) 
that promotes bud neck constriction to minimize the strain at the phase boundary. If large enough, this 
force can drive spontaneous membrane deformation, bud formation, bud neck thinning and, ultimately, 
bud scission [28]. Overall, this model is very attractive and satisfyingly supported by the experimental 
findings.  Although  Rossman  et  al.  demonstrate  that  mutation  of  the  amphipathic  helix  residues 
significantly  reduces  viral  titers  in  cell  culture  experiments  using  the  Udorn  strain  of  influenza 
virus [29],  mutation  of  residues  within  the  helix  had  no  effect  on  virus  growth  in  cell  culture 
experiments using the WSN strain [30]. The explanation for this discrepancy may lie in the fact that 
two of the three mutations generated by Stewart et al. [30] do not lie on the hydrophobic side of the 
amphipathic helix. It would be of interest to determine the effect of changing bulky hydrophobic 
residues  to  alanine  within  the  amphipathic  helix  in  the  WSN  background.  Alternatively,  the 
discrepancy might reflect the fact that the Udorn virus has a filamentous morphology while WSN is 
spherical.  Also,  we  noted  no  apparent  homology  between  the  influenza  type  A  and  type  B  M2 
cytoplasmic tails and, moreover, the type B residues that align with the type A amphipathic helix are 
not predicted to form a similar structure. It will be interesting to determine whether the influenza type 
B viruses bud using a similar ESCRT-independent mechanism. Like M2, ESCRT-1 and -2 localize to 
the neck of budding retroviral particles [31]. Whether assisted by the ESCRT-3 complex or the M2 
protein, a fundamental condition for success in bud scission may be the induction of line tension. The 
inherent line tension-generating property of the raft/non-raft boundary may explain why influenza 
virus, HIV-1 and other viruses utilize lipid rafts as their budding platform [32].  
3. Budding Directed by Other Influenza Virus Proteins 
Influenza  type  A  virus  is  unique  in  having  several  virus-encoded  proteins  that  are  capable  of 
budding on their own. The HA/NA complex, M1 and some isoforms of the NA can also drive particle 
release when expressed in the absence of any other viral proteins in a plasmid-based system that 
generates  spherical  VLPs  [2,3–6].  The  efficiency  of  M2-mediated  budding  relative  to  HA/NA-
mediated budding is very low [2]. While the co-expression of HA/NA and M2 does generate a boost in 
HA/NA VLP yield, this boost is very modest [2]. This result suggests that other factors are capable of 
contributing to the scission event. Indeed, Gomez-Puertas et al. [4] showed earlier that the M1 protein, 
when  expressed  alone,  assembles  into  virus-like  budding  particles,  which  are  released  in  the  Viruses 2011, 3                         
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culture  medium.  In  their  studies,  M1  was  the  only  viral  component  essential  for  VLP  formation.  
Latham et al. [5] investigated the minimal number of structural proteins necessary for VLP assembly 
and release using single-gene baculovirus recombinants that expressed in Sf9 cells either the HA, NA, 
M1 or the M2 proteins of influenza virus A/Udorn/72 (H3N2). Expression of M1 protein alone led to 
the release of VLPs. Wang et al. [33] found that native M2 but not mutant M2 lacking the cytoplasmic 
tail,  effectively  targeted  M1  to  the  plasma  membrane  and  produced  extracellular  M1  VLPs. 
Interestingly however, these investigators observed that M2 did not bud efficiently as compared with 
M1  plus  M2.  It  is  important  to  note  that  these  observations  are  based  on  studies  in  the  VLP 
background.  Whether  M2  alone  is  necessary  for  the  budding  of  influenza  virus  has  not  yet  been 
determined. M2 certainly contributes to virus budding, as apparent by the 5-log decrease in titer that 
Rossman obtained using their M2-mutated virus. Whether all of the decrease is attributed to budding 
deficiency  is  not  known. While  the VLP system is  very useful  to  determine which  viral proteins 
contain the necessary determinants of budding and provides the benefit of assessing their relative 
efficiency in this process, studies in the context of the virus must ultimately be used to determine the 
interplay between the proteins. Perhaps the budding properties observed for M2, M1, HA and NA 
reflect  a  redundancy  of  this  critical  function,  analogous  to  retroviral  primary  and  secondary  Late 
domain determinants. 
VLPs  produced  by  HA/NA  or  NA  alone  exhibit  very  similar  morphology  [3,6].  Side-by-side 
comparisons of this morphology with that of M2-derived VLPs have not yet been performed. HA/NA 
and NA budding have yet to be examined in the GUVs budding assay to determine whether, like M2, 
these proteins can mediate all the membrane events required for budding. Interference with Vps4 
function by siRNA-mediated depletion or co-expression of influenza virus with dominant-negative 
(DN) interfering mutants of Vps4 did not inhibit virus budding [19,34]. Similarly, release of budding-
competent NA isoforms exhibited resistance to disruption of Vps4 function [7]. Thus, like M2 and the 
intact influenza virus, NA budding is not inhibited by disruption of the ESCRT machinery through DN 
Vps4 expression.  
Certainly,  the  results  obtained  by  Rossman  et  al.  [1]  raise  many  exciting  questions  that  will 
stimulate investigations to elucidate the underlying mechanism of M2’s contribution to budding. It will 
also  be  very  interesting  to  determine  if  functional  equivalents  of  M2  are  encoded  in  other  virus 
families budding by ESCRT-independent mechanisms.  
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